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Ovarian cancer remains one of the main causes of death in all gynecologic malignancies.1 
Natural products continue to be important sources of clinically approved anti-cancer drugs.2-3 
Triclisia subcordata Oliv (Menispermeaceae) is a medicinal plant traditionally used for the 
treatment of various diseases,4 including cancer, in West Africa. This study aims to evaluate 
the in vitro anti-ovarian cancer activities of the crude extracts and the isolated components in 
T. subcordata. The ethanol extract of T. subcordata and its fractions (crude alkaloids) were 
screened for in vitro anti-ovarian cancer activities on Ovcar-8, Ovcar-4, A2780, and Igrov-1 
ovarian cancer cell lines using the Sulforhodamine B assay method to measure cell growth. 
Bioassay-guided fractionation using silica gel column chromatography and HPLC were used to 
isolate the bioactive compound, whose identity and structure was identified by NMR and LC-
MS techniques. Caspase and PARP cleavage assays were used to detect apoptotic activities. 
The effect of isolated pure compounds on cell cycle and apoptosis was analyzed by flow 
cytometry. Results: The crude alkaloids showed the strongest activity in cell growth assays on 
A2780 and Ovcar-8 cell lines (IC50 < 2.4 µg/mL). A bisbenzylisoquinoline alkaloid-cycleanine 
was isolated using HPLC and identified by MS and NMR analyses. The IC50 values of cycleanine 
and tetrandrine (an alkaloid previously reported from this plant) ranged from 7 to 14 µM on 
A2780, Ovcar-8, Ovcar-4 and Igrov-1 ovarian cancer cell lines. The IC50 of cycleanine on 
human normal ovarian surface epithelial cells was 35 ± 1 µM hinting at modest selectivity 
towards cancer cells. Both cycleanine and 
tetrandrine caused apoptosis as shown by 
activation of caspases 3/7 (increased levels 
of caspases 3/7) and cleavage of poly (ADP) 
ribose polymerase (PARP) to form PARP-I. 
The percentage of Ovcar-8 cells in subG1 
phase increased after exposure of 
cycleanine and tetrandrine to cells for 48h compared to control.  In conclusion, cycleanine, like 
its isomer – tetrandrine isolated from Triclisia subcordata, could be a potential new anti-
ovarian cancer agent acting through the apoptosis pathway. 
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